Catalogue Search | MBRL
Are you sure you want to remove the book from the shelf?
{{itemTitle}}
2,169
result(s) for
"LUXEMBOURG"
Sort by:
Luxembourg : the Bradt Travel Guide
\"This new, fully updated fourth edition of Bradt's Luxembourg remains the only comprehensive English-language guide to focus exclusively on this small but fascinating European country. Included are detailed reviews of the best places to stay and eat in all price categories, from luxury to budget; information about every museum and significant place of interest in the country; in-depth guides to local food, drink, language and culture; and guides to the best cycling and hiking trails, many of the latter having been personally tested and explored by the author.\"--Provided by publisher.
Book
Inventing Luxembourg
The grand duchy of Luxembourg is a showcase example for the constructed nature of national identities. This book explores this construction process from the nineteenth to the twenty-first century, focusing on representations of the past, space and language.
eBook
Belgium & Luxembourg
DK Eyewitness Travel Guide: Belgium & Luxembourg will lead you straight to the best attractions these countries have to offer. Packed with photographs, illustrations, and maps of Belgium and Luxembourg, the guide includes in-depth coverage of the region's best attractions, from fine art in Brussels to the canals of Bruges, the battlefields of Flanders and the best castles, museums, and architecture in between.
Book
Constructing the Middle Ages : historiography, collective memory and nation-building in Luxembourg
The Middle Ages provide important points of reference during the nation-building process in Luxembourg. This book deconstructs the traditional narrative of that period, with its function as a time of national origins and national heroes.
eBook
Belgium & Luxembourg
Lonely Planet's Belgium & Luxembourg is your passport to the most relevant, up-to-date advice on what to see and skip, and what hidden discoveries await you. Explore Unesco-listed belfries in Bruges and Tournai, savour Belgian pralines at a Brussels chocolatier and stroll along the river gorge in Luxembourg City - all with your trusted travel companion. Get to the heart of Belgium & Luxembourg and begin your journey now!
Book
Usutu Virus Africa 3 Lineage, Luxembourg, 2020
We detected Usutu virus in a dead Eurasian blackbird (Turdus merula) in Luxembourg in September 2020. The strain clustered within the Africa 3.1 lineage identified in Western Europe since 2016. Our results suggest maintenance of the virus in Europe despite little reporting during 2019-2020, rather than a new introduction.
Journal Article
Geographic Distribution of Raccoon Roundworm, Baylisascaris procyonis , Germany and Luxembourg
Infestation with Baylisascaris procyonis, a gastrointestinal nematode of the raccoon, can cause fatal disease in humans. We found that the parasite is widespread in central Germany and can pose a public health risk. The spread of B. procyonis roundworms into nematode-free raccoon populations needs to be monitored.
Journal Article
Fabricating modern societies : education, bodies, and minds in the age of steel
\"Fabricating Modern Societies: Education, Bodies, and Minds in the Age of Steel, edited by Karin Priem and Frederik Herman, offers new interdisciplinary and transnational perspectives on the history of industrialization and societal transformation in early twentieth-century Luxembourg. The individual chapters focus on how industrialists addressed a large array of challenges related to industrialization, borrowing and mixing ideas originating in domains such as corporate identity formation, mediatization, scientification, technological innovation, mechanization, capitalism, mass production, medicalization, educationalization, artistic production, and social utopia, while competing with other interest groups who pursued their own goals. The book looks at different focus areas of modernity, and analyzes how humans created, mediated, and interacted with the technospheres of modern societies\"-- Provided by publisher.
Book
Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
Background
The PROOF registry is an observational study initiated in October 2013 with the aim to monitor disease progression in a real-world population of patients with idiopathic pulmonary fibrosis (IPF). Here, we present longitudinal clinical outcomes from the PROOF registry.
Methods
Patients with IPF were enrolled across eight centers in Belgium and Luxembourg. For all patients, clinical outcomes data were collected, including mortality, lung transplant, acute exacerbations, and pulmonary hypertension. For patients treated with pirfenidone at any time during follow-up (2013–2017), for any duration of treatment (the pirfenidone-treated population): pirfenidone treatment patterns were collected; changes in pulmonary function (forced vital capacity [FVC] and carbon monoxide diffusing capacity [DLco]) were reviewed up to 24 months post-inclusion; and time-to-event analyses from the time of registry inclusion were performed.
Results
The PROOF registry enrolled a total of 277 patients. During follow-up, 23.1% of patients died, 5.1% received a lung transplant, 5.4% experienced an acute exacerbation, and 6.1% had comorbid pulmonary hypertension. In the pirfenidone-treated population (
N
= 233, 84.1%), 12.9% of patients had a temporary dose discontinuation and 31.8% had a temporary dose reduction; 4.3% of patients permanently discontinued pirfenidone due to an adverse drug reaction. Mean percent predicted FVC was 81.2% (standard deviation [SD] 19.0) at Month 0 and 78.3% (SD 25.0) at Month 24, and mean percent predicted DLco was 47.0% (SD 13.2) and 45.0% (SD 16.5), respectively. Rates of ≥ 10% absolute decline in percent predicted FVC and ≥ 15% absolute decline in percent predicted DLco over 24 months were 31.0% and 23.2%, respectively. Mean times from registry inclusion to categorical absolute decline in percent predicted FVC and percent predicted DLco were 20.1 (standard error [SE] 0.6) months and 23.4 (SE 0.5) months, respectively; mean time from registry inclusion to death was 31.0 (SE 0.9) months.
Conclusions
The PROOF registry is a source of European data characterizing longitudinal clinical outcomes of patients with IPF. Over 12 months of follow-up, pulmonary function remained largely stable in patients with IPF who received pirfenidone for any duration of treatment. Pulmonary function remained similar at 24 months of follow-up, although patient numbers were lower.
Trial registration
PROOF is registered with the relevant authorities in Belgium and Luxembourg, with registration to Comité National d’Éthique et de Recherche (CNER) N201309/03–12 September 2013 and a notification to Comité National de Protection des Données (CNDP) for Luxembourg.
Journal Article